Abbott India Limited | ABBOTINDIA | NSE - Pharmaceuticals
INR in Million. Fiscal year ends in March. Figures are consolidated and restated..
Upgrade Membership to see 10 year accurate financial statements.
Chart | 2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|---|
Revenue |
| 29,387 | 33,071 | 36,786 | 40,931 | 43,909 |
Cost of revenue |
| -17,121 | -19,047 | -20,886 | -23,157 | -23,909 |
Gross Profit |
| 12,266 | 14,024 | 15,900 | 17,775 | 20,000 |
Sales, general & ad... |
| -7,932 | -8,693 | -9,853 | -10,210 | -9,976 |
Depreciation |
| -164 | -162 | -169 | -596 | -581 |
Provision |
| 0 | 0 | 0 | 0 | 0 |
Other op inc/exp... |
| -361 | -86 | 0 | 0 | 0 |
Operating income |
| 3,809 | 5,083 | 5,878 | 6,968 | 9,442 |
Profit before tax |
| 4,365 | 6,215 | 6,989 | 8,027 | 9,260 |
Net Income |
| 2,766 | 4,012 | 4,503 | 5,929 | 6,907 |
| | | | | ||
EPS Basic |
| 130.19 | 188.81 | 211.93 | 279.04 | 325.04 |